Table III.
Etiologic Agent of Viral Respiratory Infection in Patients With or Without Influenza‐like Illness (According to the CDC's Definition) From June 2009 to January 2010 in Marseille, France
| Virus | Clinical presentation | P‐value | |
|---|---|---|---|
| Influenza‐like illness | Non‐influenza‐like illness | ||
| A/H1N1p | 100 (27.9) | 30 (25.4) | 0.596 |
| EV | 1 (0.3) | 1 (0.8) | 0.406 |
| HRV | 27 (7.5) | 7 (5.9) | 0.537 |
| hMPV | 1 (0.3) | 0 | 0.565 |
| hCoV OC43 | 5 (1.4) | 1 (0.8) | 0.641 |
| PIV 1 | 4 (1.1) | 1 (0.8) | 0.803 |
| PIV 2 | 0 | 0 | |
| PIV 4 | 2 (0.6) | 1 (0.8) | 0.728 |
| AdV | 3 (0.8) | 0 | 0.315 |
| Negative for all viruses tested | 108 (30.2) | 39 (33.1) | 0.311 |
| Not tested for respiratory viruses | 109 (30.4) | 39 (33.1) | 0.596 |
| Total | 358 | 118 | |
ADV, adenovirus; hCoV OC43, human coronavirus OC43; EV, enterovirus; hMPV, human metapneumovirus; HRV, rhinovirus; A/H1N1p, 2009 pandemic A/H1N1 influenza virus; PIV, parainfluenza virus.